Financial intelligence for Asia's healthcare markets
 
 
Remember me:



News

Shanghai-based 111 Inc, an integrated online and offline healthcare platform, today announced its results for the second quarter of 2020, as well as a significant capital injection.
Beijing-based China Biologic Products Holdings, a plasma-based biopharmaceutical company, announced its net income decreased by 14.2% to $35.7 million from $41.6 million in the same quarter of 2019.
Huami Corporation, a healthcare services provider and smart wearable technology company, has announced second quarter net income of ¥13.3 million ($1.9 million).
Shanghai-based cardiac device company Hanyu Medical has completed a ¥500 million ($72.05 million) Series D round financing co-led by Highlight Capital, CITIC Private Equity Funds Management, and Yingke PE.
China Pharma Holdings, an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, has announced net income of $13,000 for the second quarter of 2020.
WuXi AppTec Co, which provides a broad portfolio of R&D and manufacturing services for companies in the pharmaceutical, biotech and medical device industries, has announced Q2 profit of ¥1.4 million ($204.8 million).
Chinese clinical-stage antimicrobial drug developer MicuRx Pharmaceuticals has raised ¥300 million ($43.1 million) in a Series D funding roumd led by HG Capital.
Shanghai-based biotech firm Lepu Biotech has completed a ¥1.291 billion ($186 million) Series B funding round by Riverhead Capital, Sunshine Insurance Group and Ping An Capital.



Features

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


HealthInvestor Asia twitter feed


Latest analysis

Shifting sands

Fabio La Mola L.E.K. Consulting's Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes - creating significant opportunities for investors in the region.

Read the full feature here





Free trial

HealthInvestor UK